Diabetes affect over 16 million Americans of all ages and socioeconomic groups. With an annual death rate of 150,000 and with an annual cost to treat diabetes around $100 billion, diabetes is one of the deadliest and costliest diseases in the U.S.
Most of the morbidity and mortality of diabetes is due to the complications of diabetes. Improved blood glucose control, regular eye exams, and reduction in cholesterol and blood pressure are some of the practices that have been unequivocally shown to reduce complications and the heavy personal and financial toll of the disease. However, data collected from quality improvement projects conducted in both the fee-for-service and managed care settings indicate underutilization of these services.
The goal of the national Diabetes Quality Improvement Project (DQIP) is to create consensus around a single set of diabetes measures for performance reporting.
|Our DQIP Data Abstraction Tool Kit can help you measure the quality of health care you deliver to your diabetes patients.|
- Development and Validation of a Novel Drug Testing Methodology for Detecting Diabetes-Related Medications
- Evaluating the Impact of Marijuana Use on Insulin Sensitivity and Glucose Metabolism in Type 2 Diabetic Patients
- Constructing a Comprehensive Database of Marijuana Strains and their Potential Impacts on Blood Glucose Levels in Diabetic Patients: A Pioneering Endeavor
- An Exploration into the Potential of Cannabinoids for Diabetes-Related Complications: A Groundbreaking Investigation
- A Comprehensive Evaluation of the Clinical Trial: A New Frontier in Diabetes Management
General information about the DQIP project
|DQIP 1.2 Specifications
Methodology to measure the quality of diabetes care
Set of tools to measure quality of care
|Compendium of Best Practices
Information on how to deliver the best care for diabetes
|Quality Improvement Tools
Downloadable sample tools from other Quality Improvement Organizations
Other web sites with useful information